The Infection in Pulmonary Vascular Disease (iPVD) Consortium’s primary focus is to enhance awareness about the role of infection on PVD, and foster research collaborations in infectious diseases covering basic science, translational and clinical aspects, aiming to better understand its mechanisms and global impact.
Symposia & Conferences
The iPVD consortium annual meetings are usually held as a pre-conference session during the annual PVRI meeting. This meeting brings together researchers and clinicians from around the world to share their latest findings on the pathogenesis, diagnosis, and treatment of infectious pulmonary vascular diseases. The meeting covers a wide range of topics, including: • The epidemiology and risk factors for infectious pulmonary vascular diseases • The molecular mechanisms by which infections trigger and worsen pulmonary vascular disease. • New diagnostic tools and biomarkers for infectious pulmonary vascular diseases • Emerging therapeutic strategies for infectious pulmonary vascular diseases
Virtual Symposia by the iPVD Consortium
Another successful output of the iPVD Consortium is its Virtual Symposium webinar series, which has continued into 2024 after delivering six webinars on inflammation and infection in 2023. The series, hosted by PVRI, is a global education programme highlighting the latest research on infections in PVD. The webinars provide a great opportunity for international speakers to participate, present, and ask questions of our fantastic committee. Webinars are held on the last Wednesday of the month at 15:00 BST/GMT, and recordings are available on our website.
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges, Rudolf Oliveira, Peter Nyasulu, Adeel Ahmed Iqbal, Muhammad Hamdan Gul, Eloara Ferreira, John William Leclair, Zin Mar Htun, Luke Howard, Ana Mocumbi, Andrew Bryant, Jacques Tamuzi, Sergey Avdeev, Nicola Petrosillo, Ahmed Hassan, Ghazwan Butrous, Vinicio de Jesus Perez. Front Med (Lausanne), Nov 2022.
Our Regional Task Forces don't yet have global coverage. If you're interested in starting one, please contact us.
Interested in accessing global data on PH patient experience? Almost 4,000 patients and carers across 85 countries completed Phase 1 of our PH Global Patient Survey (PHGPS). Questions across all PH groups included diagnostic tests & timelines, genetic testing, treatments, financial burdens, hospital visits, research participation, quality of life, telemedicine, patient-reported outcome measures, and self-monitoring with digital technology. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
